Table 1

Patient characteristics and clinical status at the time of serum collection for human IL-21 analysis

Graft sourceConditioning (full/reduced)Matching (related/unrelated)GVHD grade (0/1/2/3/4)Sample date post-treatment aGVHD history (active/none/inactive)Steroid refractory GVHD
Adult 37/14 26/25 20/14/10/5/2 23/35/24 
Cord 44/0 0/44 16/1/17/4/6 13/18/13 
Graft sourceConditioning (full/reduced)Matching (related/unrelated)GVHD grade (0/1/2/3/4)Sample date post-treatment aGVHD history (active/none/inactive)Steroid refractory GVHD
Adult 37/14 26/25 20/14/10/5/2 23/35/24 
Cord 44/0 0/44 16/1/17/4/6 13/18/13 

A total of 95 adult patients undergoing allo-HCT with cells from either adult or cord blood were used in this analysis.

or Create an Account

Close Modal
Close Modal